GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma
出版年份 2020 全文链接
标题
GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma
作者
关键词
-
出版物
JOURNAL OF NEURO-ONCOLOGY
Volume 147, Issue 3, Pages 577-585
出版商
Springer Science and Business Media LLC
发表日期
2020-05-19
DOI
10.1007/s11060-020-03470-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune check-point in glioblastoma multiforme
- (2019) F. De Felice et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The current state of immunotherapy for gliomas: an eye toward the future
- (2019) Peter E. Fecci et al. JOURNAL OF NEUROSURGERY
- Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2
- (2018) Taiji Iwasawa et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
- (2018) Christopher W. Mount et al. NATURE MEDICINE
- Concepts for Immunotherapies in Gliomas
- (2018) Michael Platten et al. SEMINARS IN NEUROLOGY
- Immunotherapy with anti-GD2 antibody ch14.18/CHO±IL2 within the HR-NBL1/SIOPEN trial to improve outcome of high-risk neuroblastoma patients compared to historical controls.
- (2018) Ruth Lydia Ladenstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors
- (2018) Giulia Golinelli et al. CANCER GENE THERAPY
- Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
- (2018) Ruth Ladenstein et al. LANCET ONCOLOGY
- Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
- (2016) Julien Fleurence et al. Oncotarget
- Disialoganglioside GD2 as a therapeutic target for human diseases
- (2015) Maya Suzuki et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes
- (2015) Azeem A. Rehman et al. Neurosurgical Focus
- Vaccine therapies for patients with glioblastoma
- (2014) Eli T. Sayegh et al. JOURNAL OF NEURO-ONCOLOGY
- Functional Bioassays for Immune Monitoring of High-Risk Neuroblastoma Patients Treated with ch14.18/CHO Anti-GD2 Antibody
- (2014) Nikolai Siebert et al. PLoS One
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started